Company intelligence / Profile preview
Wantai BioPharm
Beijing, Beijing, Chinaystwt.cn ↗
- Ownership
- Private
- Employees
- ~4000
- Development stage
- Commercial
01
Overview
Wantai BioPharm has several commercialized products in diagnostics and vaccines. Notably:
- Hecolin® Recombinant Hepatitis E Vaccine completed Phase III trials and was published in The Lancet.
- Cecolin® Recombinant HPV Vaccine received a New Drug Certificate in China.
- Multiple COVID‑19 serology and molecular tests launched globally. The company’s diagnostic kits are WHO pre-qualified and CE-marked for global use. Their nasal spray COVID vaccine has also reached the market.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- ELISA kitsrapid tests (lateral flow)chemiluminescence assaysclinical chemistry reagentsrecombinant protein vaccines (e.g. HPV and Hepatitis E)molecular diagnostics
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with Xiamen University for R&Dgovernment support via China Torch Programinternational distribution partners not specifically named in search results but implied by global product reach
Beyond the preview
Go deeper on Wantai BioPharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wantai BioPharm.